SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology CD34 products
includes other brands or spellings
|
| wb | | Santa Cruz Biotechnology mouse anti-human CD34 was used in western blot to detect CD34 expressions in early pre-eclamptic and HELLP placentae from patients as well as normal controls. |
BD BIOSCIENCES search BD Biosciences CD34 products
includes other brands or spellings
|
| flow | | Becton Dickinson FITC–labeled anti-human CD34 antibody was used in flow cytometry to investigate NKG2DL expression in leukemia cells from patients with hematopoietic malignancies. |
| flow | | Becton Dickinson allophycocyanine (APC) –labeled anti-CD34 antibody (581) was used in human MGS cells and in flow cytometry to study the association between mutations of GATA-1 gene and transient myeloproliferative disorder of Down syndrome. |
| flow | | BD Biosciences PharMingen anti-human CD34 antibody was used in human mesenchymal stem cells (hMSCs) and in flow cytometry to study the prolongation of life span of human umbilical cord blood-derived mesenchymal stem cells (UCBMSCs). |
| flow | | Becton Dickinson FITC-labeled anti-CD34 monoclonal antibody was used in flow cytometry to study expression functional C3aR in human hematopoietic stem and progenitor cells. |
| flow | | Becton Dickinson anti-CD34 antibody was used in flow cytometry to study the effect of deficiet ribosomal protein S19 in CD34+ cells generated by siRNA to block erythroid development and mimic defects seen in Diamond-Blackfan anemia. |
| ic | | BD PharMingen anti-CD34 antibody was used in immunocytochemistry to study the role of Ciliary neurotrophic factor (CNTF) to induce the dedifferenciation of adult human myoblasts via p44/p42 MAPK pathway in vitro. |
| ih | | BD Biosciences mouse monoclonal CD34 (clone 8G12) antibody was used in immunohistochemistry to study podocalyxin expression in breast cancer progression. |
| ih | | Pharmingen rat monoclonal anti-mouse CD-34 antibody was used in tissue sections from human tumors and in immunohistochemistry to study the effect of homing peptide on tumor. |
| ih | | PharMingen anti-CD34 antibody was used in cryosections from human foreskin tissue and in immunohistochemistry to study the characteristic gene expression profile of human lymphatic microvascular Ecs. |
ABCAM search Abcam CD34 products
includes other brands or spellings
|
| wb | | Abcam CD34 antibody was used in western blot to investigate the regulatoin of VEGFR2/KDR by KLF2. |
BECKMAN COULTER search Beckman Coulter CD34 products
includes other brands or spellings
|
| flow | | Beckman Coulter anti-human CD34 antibody was used in human mesenchymal stem cells (hMSCs) and in flow cytometry to study the prolongation of life span of human umbilical cord blood-derived mesenchymal stem cells (UCBMSCs). |
| flow | | Immunotech anti-human CD34 antibody was used in human mesenchymal stem cells (hMSCs) and in flow cytometry to study the prolongation of life span of human umbilical cord blood-derived mesenchymal stem cells (UCBMSCs). |
| ih | | DakoCytomation CD34 antibody was tested in immunohistochemistry by HPA (CAB000018) . |
| ih | | DakoCytomation mouse monoclonal anti-CD15 antibody was used in immunohistochemistry to study expression PAX5 in acute leukemias. |
| ih | | DAKO anti-CD34 antibody was used in immunohistochemistry to study the tissue microarray validation of Epidermal Growth Factor Receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. |
| ih | | Dako monoclonal antibody against human CD34 (clone QBEND-10) was used in immunohistochemistry to provide evidence for the clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver. |
| ih | | Dako anti-CD34 mAb QBEnd10 (mouse IgG1/kappa) was used in immunohistochemistry to determine the Intratumoral Microvessel Density (IMVD) in human non–small-cell lung cancer (NSCLC). |
| ih | | Beckman Coulter monoclonal anti-CD34 antibody that labels capillary endothelial cells was used in immunohistochemistry to detect CD34 expression in fetal kidneys. |
| ih | | DAKO monoclonal anti-CD34 antibody (Qbend) was used in paraffin sections from human tumor and in immunohistochemistry to study the value of the RECK and MMP-9 as prognostic indicator for colorectal cancer. |
| ih | | Dako Cytomation monoclonal CD34 antibody (QBEnd10) was used in immunohistochemistry to study OCT-1, OCT-2, and BOB-1/OCA-B expression in normal lymphoid tissue and in T-cell neoplasms. |
LEICA MICROSYSTEMS search Leica Microsystems CD34 products
includes other brands or spellings
|
| ih | | Novocastra Laboratories anti-CD34 antibody (QBEnd/10) was used in immunohistochemistry to study SOX18 expression in human coronary atherosclerotic lesions and investigated its potential function in vascular cells.. |
| ih | | Novocastra Laboratories monoclonal anti-human CD34 antibody was used in immunohistochemistry to study the upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T Cells in cardiac valves during inflammatory valvular heart disease. |
NITIREI
|
| ih | | Nitirei monoclonal mouse antihuman CD34 antibody was used in immunohistochemistry to study PEDF expression in ductal pancreatic adenocarcinoma. |
NICHIREI
|
| ic | | Nichirei monoclonal anti-human CD34 antibody was used in human embryo kidney 293 cells and in immunocytochemistry to study the expression of p73 in human thymic epithelial cells. |
MAXIN CO
|
| ih | | Maxin Co. anti-CD34 antibody was used in paraffin sections from human gastric carcinoma and in immunohistochemistry to study the relationship between the expression of inducible nitric oxide synthase (iNOS), vascular endothelial growth factor (VEGF), the microvascular density (MVD) and the pathological features and clinical staging of gastric cancer. |
CYTOTECH
|
| flow | | Cytotech anti-human CD34 antibody was used in human mesenchymal stem cells (hMSCs) and in flow cytometry to study the prolongation of life span of human umbilical cord blood-derived mesenchymal stem cells (UCBMSCs). |
MILTENYI BIOTECH
|
| ip | | Miltenyi Biotech monoclonal anti-CD34 antibody-coated microbeads was used in blood samples from human and in immunoprecipitation to study the role for the expression of SEMA6A in identifing an alternative IFN-gamma-dependent activation status of LCs in vivo. |
Articles Reviewed |
| 1. Shingo Ichimiya et al. p73 is expressed in human thymic epithelial cells. 2002 |
| 2. Zheng-Jun Song et al. Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer. 2002 |
| 3. Simona Podgrabinska et al. Molecular characterization of lymphatic endothelial cells. 2002 |
| 4. Ryan Reca et al. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. 2003 |
| 5. Teresa Marafioti et al. Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. 2003 |
| 6. Helmut Rainer Salih et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. 2003 |
| 7. Gang Xu et al. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. 2003 |
| 8. Torsten O Nielsen et al. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. 2003 |
| 9. Ryoko Yamauchi et al. Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. 2004 |
| 10. Hirofumi Uehara et al. Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. 2004 |
| 11. Pirjo Laakkonen et al. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. 2004 |
| 12. Aruna Somasiri et al. Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. 2004 |
| 13. Taku Takeuchi et al. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. 2004 |
| 14. Shinya Ishikawa et al. Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer. 2004 |
| 15. Enrico Tiacci et al. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. 2004 |
| 16. Johan Flygare et al. Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia. 2005 |
| 17. Joanna-W Ho et al. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver. 2005 |
| 18. Masanori Terai et al. Immortalization of human fetal cells: the life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway. 2005 |
| 19. Xiaoping Chen et al. Dedifferentiation of adult human myoblasts induced by ciliary neurotrophic factor in vitro. 2005 |
| 20. Resham Bhattacharya et al. Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. 2005 |
| 21. Marta GarcĂa-RamĂrez et al. Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growth. 2005 |
| 22. Gregory Gautier et al. The class 6 semaphorin SEMA6A is induced by interferon-gamma and defines an activation status of langerhans cells observed in pathological situations. 2006 |
| 23. Alexandra Gellhaus et al. Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. 2006 |
| 24. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 25. Mireille Lacoste et al. Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: Role of the Renin-Angiotensin system. 2006 |